Catastrophic tumour lysis syndrome following single dose of imatinib

European Journal of Haematology

Volumn 82, Issue 3, 2009, Pages 244-245

  Keane, Colm ^a   Henden, Andrea ^a   Bird, Robert ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; HYDROXYUREA; IMATINIB; LACTATE DEHYDROGENASE; RASBURICASE;

ACUTE KIDNEY FAILURE; ADULT; ANAMNESIS; BONE MARROW BIOPSY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPHOSPHATEMIA; LABORATORY TEST; LETTER; LEUKAPHERESIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SIDE EFFECT; SINGLE DRUG DOSE; TUMOR LYSIS SYNDROME;

EID: 58849089596     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2008.01186.x     Document Type: Letter

References (2)

1. Dann EJ, Fineman R, Rowe JM. Tumor lysis syndrome after STI571 in Philadelphia chromosome-positive acute lymphoblastic leukemia. J Clin Oncol 2002 20 : 354 5.
2. Vora A, Bhutani M, Sharma A, Raina V. Severe tumor lysis syndrome during treatment with STI 571 in a patient with chronic myelogenous leukemia accelerated phase. Ann Oncol 2002 13 : 1833 4.